Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Credit Suisse Maintains Neutral on Nordstrom, Lowers Price Target to $20

Credit Suisse analyst Michael Binetti maintains Nordstrom (NYSE:JWN) with a Neutral and lowers the price target from $21 to $20.

byBenzinga Newsdesk

November 23, 2022

1 minute read

Credit Suisse analyst Michael Binetti maintains Nordstrom (NYSE:JWN) with a Neutral and lowers the price target from $21 to $20.

SEE Sees FY22 Adj. EPS $4.05-$4.20 vs $4.10 Est., Sales $5.85B-$6.05B vs $5.9B Est.

By Bill Haddad

Today, 2:22 AM

r the full year 2022, SEE now expects net sales in the range of $5.85 billion to $6.05 billion, which includes an unfavorable currency impact of approximately 2% and an unfavorable divestiture impact of approximately 1%.

SEE

FDA
News

Gilead Sciences Announces FDA Also Revoked Emergency Use Authorization For Veklury That Previously Covered Children Less Than 12 Years Of Age; FDA Expanded Approval Of Covid-19 Treatment Veklury To Include Pediatric Patients 28 Days Of Age And Older We…

By Benzinga Newsdesk

Today, 2:22 AM

- Reuters

GILD

Oppenheimer Maintains Outperform on NVIDIA, Lowers Price Target to $225

By Benzinga Newsdesk

Today, 2:22 AM

Oppenheimer analyst Rick Schafer maintains NVIDIA (NASDAQ:NVDA) with a Outperform and lowers the price target from $250 to $225.

NVDA

Big Four Accounting Firms Come Under Regulator’s Scrutiny; SEC Sent Requests For Information To Deloitte & Touche, Ernst & Young, KPMG, And PricewaterhouseCoopers

By Benzinga Newsdesk

Today, 2:22 AM

-Wall Street Journal Report

SPY

Credit Suisse Maintains Neutral on Nordstrom, Lowers Price Target to $20

Related Posts

SEE Sees FY22 Adj. EPS $4.05-$4.20 vs $4.10 Est., Sales $5.85B-$6.05B vs $5.9B Est.

Gilead Sciences Announces FDA Also Revoked Emergency Use Authorization For Veklury That Previously Covered Children Less Than 12 Years Of Age; FDA Expanded Approval Of Covid-19 Treatment Veklury To Include Pediatric Patients 28 Days Of Age And Older We…

Oppenheimer Maintains Outperform on NVIDIA, Lowers Price Target to $225

Big Four Accounting Firms Come Under Regulator’s Scrutiny; SEC Sent Requests For Information To Deloitte & Touche, Ernst & Young, KPMG, And PricewaterhouseCoopers